| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
LYRA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.10M | $3.69M | - | |
| CFO | 518.5K | $1.74M | - | |
| 10% | 124.9K | $487.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2022 | Merrifield C Ann | Director | Buy | 4,000 | $5.05 | $20,200.00 | +54.6% | +24.4% | -42.0% | |
| May 16, 2022 | Merrifield C Ann | Director | Buy | 3,828 | $4.83 | $18,485.50 | +109.4% | +23.9% | -45.6% | |
| Apr 12, 2022 | Anderson Edward T | Director, 10% Owner | Buy | 2,488,150 | $4.22 | $10,499,993.00 | -105.0% | -1.8% | -59.5% | |
| Apr 12, 2022 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 5,924,170 | $4.22 | $24,999,997.40 | +306.3% | -1.8% | -59.5% | |
| Apr 12, 2022 | Waksal Harlan | Executive Chair | Buy | 236,966 | $4.22 | $999,996.52 | New | -1.8% | -59.5% | |
| Apr 12, 2022 | Nbvm Gp, LLC | 10% Owner | Buy | 2,369,667 | $4.22 | $9,999,994.74 | -225.4% | -1.8% | -59.5% | |
| Jun 17, 2021 | Merrifield C Ann | Director | Buy | 3,500 | $8.97 | $31,394.65 | New | -8.5% | -44.9% | |
| Dec 16, 2020 | Snyderman Nancy Lynn Md | Director | Buy | 1,025 | $9.72 | $9,963.00 | New | - | - | |
| May 5, 2020 | Nbvm Gp, LLC | 10% Owner | Sell | 24,183 | $16.00 | $386,928.00 | -4.8% | - | - | |
| May 5, 2020 | Soleus Private Equity GP I, LLC | 10% Owner | Sell | 16,909 | $16.00 | $270,544.00 | -3.6% | - | - |